Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-17-004113
Filing Date
2017-08-21
Accepted
2017-08-21 15:51:19
Documents
53
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q imle_10q.htm 10-Q 476437
2 FORM OF SERIES A PREFERRED STOCK PURCHASE AGREEMENT imle_ex107.htm EX-10.7 39289
3 FORM OF AMENDMENT NO. 1 TO SERIES A PREFERRED STOCK PURCHASE AGREEMENT imle_ex108.htm EX-10.8 10129
4 CERTIFICATION imle_ex311.htm EX-31.1 8013
5 CERTIFICATION imle_ex312.htm EX-31.2 7521
6 CERTIFICATION imle_ex321.htm EX-32.1 3430
7 CERTIFICATION imle_ex322.htm EX-32.2 3490
  Complete submission text file 0001477932-17-004113.txt   4771759

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT imle-20170630.xml EX-101.INS 1383460
9 XBRL TAXONOMY EXTENSION SCHEMA imle-20170630.xsd EX-101.SCH 64708
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imle-20170630_cal.xml EX-101.CAL 35418
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imle-20170630_def.xml EX-101.DEF 173269
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE imle-20170630_lab.xml EX-101.LAB 289678
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imle-20170630_pre.xml EX-101.PRE 231258
Mailing Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705
Business Address 400 N. TUSTIN AVE. SUITE 225 SANTA ANA CA 92705 714-667-7139
TransBiotec, Inc. (Filer) CIK: 0001425627 (see all company filings)

EIN.: 260731818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53316 | Film No.: 171043111
SIC: 2721 Periodicals: Publishing or Publishing & Printing